TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993,488 | -47.7% | 118,856 | +55.4% | 0.00% | -66.7% |
| Q2 2023 | $1,901,346 | +128.2% | 76,483 | +38.7% | 0.00% | +50.0% |
| Q1 2023 | $833,277 | +93.8% | 55,143 | +51.3% | 0.00% | +100.0% |
| Q4 2022 | $430,000 | +140.2% | 36,447 | +19.7% | 0.00% | – |
| Q3 2022 | $179,000 | +26.1% | 30,440 | -8.0% | 0.00% | – |
| Q2 2022 | $142,000 | -56.7% | 33,103 | -3.9% | 0.00% | -100.0% |
| Q1 2022 | $328,000 | -25.6% | 34,433 | +49.5% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | -62.1% | 23,027 | -34.1% | 0.00% | -50.0% |
| Q3 2021 | $1,164,000 | +3.3% | 34,924 | +20.3% | 0.00% | 0.0% |
| Q2 2021 | $1,127,000 | -5.0% | 29,025 | +17.9% | 0.00% | -33.3% |
| Q1 2021 | $1,186,000 | -4.3% | 24,621 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $1,239,000 | +33.7% | 23,801 | -31.2% | 0.00% | 0.0% |
| Q3 2020 | $927,000 | +104.2% | 34,587 | +48.9% | 0.00% | +50.0% |
| Q2 2020 | $454,000 | +69.4% | 23,231 | -14.4% | 0.00% | +100.0% |
| Q1 2020 | $268,000 | – | 27,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |